Molecular, typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus eaecium in Brazil

被引:18
作者
Cereda, RF
Gales, AC
Silbert, S
Jones, RN
Sader, HS
机构
[1] Univ Fed Sao Paulo, Div Infect Dis, Lab Especial Microbiol Clin, BR-04023063 Sao Paulo, Brazil
[2] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
关键词
D O I
10.1086/501962
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: To characterize vancomycin-resistant enterococci (VRE) isolates and to evaluate the mode of dissemination of this pathogen in Brazil. DESIGN: We collected 22 vancomycin-resistant Enterococcus faecium isolates from 6 medical centers in Sao Paulo, Brazil, and 1 isolate from a medical center in Curitiba, Brazil. PARTICIPANTS: All Brazilian hospitals that had identified vancomycin-resistant E. faecium up to the beginning of this study gate 1999) contributed isolates to the study, METHODS: The isolates were susceptibility tested using the broth microdilution method and the E-test. The presence of vancomycin resistance genes (vanA vanB, vanC1, vanC2-3, and vanD) was evaluated by polymerase chain reaction; molecular typing was performed by pulsed-field gel electrophoresis (PFGE). RESULTS: The vanA gene was demonstrated in all vancomycin-resistant E. faecium, except for 1 isolate. None of the vancomycin resistance genes cited above was detected in the isolate from Curitiba, which was the first vancomycin-resistant E. faecium described in Brazil. An isolates were resistant to ampicillin and teicoplanin. The main clone remains susceptible to doxycycline and chloramphenicol, but intermediate to quinupristin-dalfopristin. PFGE analysis demonstrated 7 major PFGE patterns. A unique PFGE pattern with 4 subtypes was detected in 17 isolates from 4 different hospitals. CONCLUSION: The results of our study indicate the occurrence of intra- and interhospital dissemination of VRE in Sao Paulo, Brazil.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 23 条
[1]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[2]  
[Anonymous], M100S10 NCCLS
[3]  
Cereda, 1997, Braz J Infect Dis, V1, P83
[4]  
CEREDA RF, 1998, 98 GEN M AM SOC MICR
[5]   Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil [J].
Dalla Costa, LM ;
Reynolds, PE ;
Souza, HAPHM ;
Souza, DC ;
Palepou, MFI ;
Woodford, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3444-3446
[6]  
DALLACOSTA LM, 1998, BRAZ J INFECT DIS, V2, P160
[7]  
DUTKAMALEN S, 1995, J CLIN MICROBIOL, V30, P1621
[8]  
Facklam R.R.S., 1999, Manual of Clinical Microbiology, P297
[9]   Antimicrobial activity of quinupristin-dalfopristin (RP 59500, synercid®) tested against over 28,000 recent clinical isolates from 200 medical centers in the united states and Canada [J].
Jones, RN ;
Ballow, CH ;
Biedenbach, DJ ;
Deinhart, JA ;
Schentag, JJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 31 (03) :437-451
[10]   Resistance to glycopeptides in enterococci [J].
Leclercq, R ;
Courvalin, P .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :545-556